1. Brea, A.; Mosquera, D.; Martin, E.; Arizti, A.; Cordero, J.L.; Ros, E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: case-control study. Arter. Thromb Vasc Biol 2005, 25, 1045–1050. [CrossRef] [PubMed]
2. Targher, G.; Arcaro, G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007, 191, 235–240. [CrossRef] [PubMed]
3. Li, X.; Mingfeng, X.; Ma, H.; Hofman, A.; Hu, Y.; Yan, H.; He, W.; Lin, H.; Jeekel, J.; Zhao, N.; et al. Liver fat content is associated with increased carotid atherosclerosis in Chinese middle-agedand elderly population: Shanghai Changfeng study. Atherosclerosis 2012, 224, 480–485. [CrossRef] [PubMed]
4. Targher, G.; Bertolini, L.; Padovani, R.; Rodella, S.; Zoppini, G.; Zenari, L.; Cigolini, M.; Falezza, G.; Arcaro, G. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006, 29, 1325–1330. [CrossRef] [PubMed]
5. Schindhelm, R.K.; Diamant, M.; Bakker, S.J.; van Dijk, R.A.; Scheffer, P.G.; Teerlink, T.; Kostense, P.J.; Heine, R.J. Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. Eur. J. Clin Invest. 2005, 35, 369–374. [CrossRef]
6. Chen, C.H.; Nien, C.K.; Yang, C.C.; Yeh, Y.H. Association between nonalcoholic fatty liver disease and coronary artery calcification. Dig. Dis Sci 2010, 55, 1752–1760. [CrossRef]
7. Akabame, S.; Hamaguchi, M.; Tomiyasu, K.; Tanaka, M.; Kobayashi-Takenaka, Y.; Nakano, K.; Oda, Y.; Yoshikawa, T. Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). Circ. J. 2008, 72, 618–625. [CrossRef]
8. Kim, B.J.; Kim, N.H.; Kim, B.S.; Kang, J.H. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals. Cardiology 2012, 123, 54–61. [CrossRef]
9. Park, G.M.; Yun, S.C.; Cho, Y.R.; Gil, E.H.; Her, S.H.; Kim, S.H.; Jo, M.W.; Lee, M.S.; Lee, S.W.; Kim, Y.H. Prevalence of coronary atherosclerosis in an Asian population: findings from coronary computed tomographic angiography. Int J. Cardiovasc Imaging 2015, 31, 659–668. [CrossRef]
10. Tesche, C.; Plank, F.; De Cecco, C.N.; Duguay, T.M.; Albrecht, M.H.; Varga-Szemes, A.; Bayer, R.R., 2nd; Yang, J.; Jacks, I.L.; Gramer, B.M.; et al. Prognostic implications of coronary CT angiography-derived quantitative markers for the prediction of major adverse cardiac events. J. Cardiovasc Comput Tomogr. 2016, 6, 8–465. [CrossRef]
11. Oudkerk, M.; Stillman, A.E.; Halliburton, S.S.; Kalender, W.A.; Möhlenkamp, S.; McCollough, C.H.; Vliegenthart, R.; Shaw, L.J.; Stanford, W.; Taylor, A.J.; et al. Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int J. Cardiovasc Imaging 2008, 24, 645–671. [CrossRef] [PubMed]
12. Sinn, D.H.; Kang, D.; Chang, Y.; Ryu, S.; Gu, S.; Kim, H.; Seong, D.; Cho, S.J.; Yi, B.K.; Park, H.D. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study. Gut 2017, 66, 323–329. [CrossRef] [PubMed]
13. Fujita, K.; Nozaki, Y.; Wada, K.; Yoneda, M.; Fujimoto, Y.; Fujitake, M.; Endo, H.; Takahashi, H.; Inamori, M.; Kobayashi, N.; et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 2009, 50, 772–780. [CrossRef] [PubMed]
14. Imajo, K.; Hyogo, H.; Yoneda, M.; Honda, Y.; Kessoku, T.; Tomeno, W.; Ogawa, Y.; Taguri, M.; Mawatari, H.; Nozaki, Y.; et al. LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study. Plos One 2014, 9, e115403. [CrossRef]
15. Kleiner, D.E.; Brunt, E.M.; Van Natta, M.; Behling, C.; Contos, M.J.; Cummings, O.W.; Ferrell, L.D.; Liu, Y.C.; Torbenson, M.S.; Unalp-Arida, A.; et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41, 1313–1321. [CrossRef]
16. Hagström, H.; Nasr, P.; Ekstedt, M.; Kechagias, S.; Stål, P.; Bedossa, P.; Hultcrantz, R. SAF score and mortality in NAFLD after up to 41 years of follow-up. Scand J. Gastroenterol 2017, 52, 87–91. [CrossRef]
17. Brunt, E.M. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001, 21, 3–16. [CrossRef]
18. Agatston, A.S.; Janowitz, W.R.; Hildner, F.J.; Zus- mer, N.R.; Viamonte, M., Jr.; Detrano, R. Quan- tification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll Cardiol 1990, 15, 827–832. [CrossRef]
19. Kumamaru, K.K.; Kondo, T.; Kumamaru, H.; Amanuma, M.; George, E.; Rybicki, F.J. Repeat coronary computed tomographic angiography in patients with a prior scan excluding significant stenosis. Circ Cardiovasc Imaging 2014, 7, 788–795. [CrossRef]
20. Lee, J.I.; Kim, M.C.; Moon, B.S.; Song, Y.S.; Han, E.N.; Lee, H.S.; Son, Y.; Kim, J.; Han, E.J.; Park, H.J.; et al. The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease. Endocrinol Metab 2016, 3, 86–92. [CrossRef]
21. Lee, M.K.; Park, H.J.; Jeon, W.S.; Park, S.E.; Park, C.Y.; Lee, W.Y.; Oh., K.W.; Park, S.W.; Rhee, E.J. Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study. Cardiovasc. Diabetol. 2015, 14, 88. [CrossRef] [PubMed]
22. Jaruvongvanich, V.; Wirunsawanya, K.; Sanguankeo, A.; Upala, S. Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis. Dig. Liver Dis 2016, 48, 1410–1417. [CrossRef] [PubMed]
23. Kim, D.; Choi, S.Y.; Park, E.H.; Lee, W.; Kang, J.H.; Kim, W.; Kim, Y.J.; Yoon, J.H.; Jeong, S.H.; Lee, D.H.; et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 2012, 56, 605–613. [CrossRef] [PubMed]
24. Yoon, Y.E.; Chang, S.A.; Choi, S.I.; Chun, E.J.; Cho, Y.S.; Youn, T.J.; Chung, W.Y.; Chae, I.H.; Choi, D.J.; Chang, H.J. The absence of coronary artery calcification does not rule out the presence of significant coronary artery disease in Asian patients with acute chest pain. Int J. Cardiovasc Imaging 2012, 28, 389–398. [CrossRef]
25. Puchner, S.B.; Lu, M.T.; Mayrhofer, T.; Liu, T.; Pursnani, A.; Ghoshhajra, B.B.; Truong, Q.A.; Wiviott, S.D.; Fleg, J.L.; Hoffmann, U.; et al. High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. Radiology 2015, 274, 693–701. [CrossRef]
26. Adams, L.A.; Anstee, Q.M.; Tilg, H.; Targher, G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017, 66, 1138–1153. [CrossRef]
27. Després, J.P.; Lamarche, B.; Mauriège, P.; Cantin, B.; Dagenais, G.R.; Moorjani, S.; Lupien, P.J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J. Med. 1996, 334, 952–957. [CrossRef]
28. Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J. Med. 2005, 352, 1685–1695. [CrossRef]
29. Imajo, K.; Fujita, K.; Yoneda, M.; Shinohara, Y.; Suzuki, K.; Mawatari, H.; Takahashi, J.; Nozaki, Y.; Sumida, Y.; Kirikoshi, H.; et al. Plasma free choline is a novel non- invasive biomarker for early-stage non-alcoholic steatohepatitis: A multi-center validation study. Hepatol Res. 2012, 42, 757–766. [CrossRef]
30. Imajo, K.; Yoneda, M.; Fujita, K.; Kessoku, T.; Tomeno, W.; Ogawa, Y.; Shinohara, Y.; Sekino, Y.; Mawatari, H.; Nozaki, Y.; et al. Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis. J. Gastroenterol 2013, 49, 295–304. [CrossRef]
31. Packard, C.J. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans. 2003, 31, 1066–1069. [CrossRef] [PubMed]
32. Krauss, R.M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 2004, 27, 1496–1504. [CrossRef] [PubMed]
33. Williams, P.T.; Superko, H.R.; Haskell, W.L.; Alderman, E.L.; Blanche, P.J.; Holl, L.G.; Krauss, R.M. Smallest LDL particles are most strongly related to coronary disease progression in men. Arter. Thromb Vasc Biol 2003, 23, 314–321. [CrossRef] [PubMed]
34. Vilar-Gomez, E.; Calzadilla-Bertot, L.; Wong, V.W.S.; Castellanos, M.; Aller-de la Fuente, R.; Metwally, M.; Eslam, M.; Gonzalez-Fabian, L.; Alvarez-Quiñones Sanz, M.; Conde-Martin, A.F.; et al. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study. Gastroenterology 2018, 155, 443–457. [CrossRef]